Rifabutin
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f33561b9-47cb-411c-a228-16c62e346cd4 | Product name | 1 | 20200415 |
| 48b3639b-9f6e-fb03-0720-42e7d1e139ac | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-016-01 | Rifabutin | 50 g in 1 JAR | POWDER | 50 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73309-016 | 73309-016-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| RIFABUTIN | 1W306TDA6S | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rifabutin | RIFABUTIN | REMEDYREPACK INC. | 25a60937-cbbe-4a50-994f-2ce15203f589 | 2026-09-01 | Warnings, Adverse reactions | Rifabutin RIFABUTIN |
| Rifabutin | RIFABUTIN | Mylan Pharmaceuticals Inc. | c2026b67-4755-4236-96b6-a6b5e7399707 | 2026-07-20 | Warnings, Adverse reactions | Rifabutin RIFABUTIN |
| Rifabutin | RIFABUTIN | REMEDYREPACK INC. | 754d2d7f-f0db-4f89-8fcd-5e2ff52d5030 | 2026-06-05 | Warnings, Adverse reactions | Rifabutin RIFABUTIN |
| Rifabutin | RIFABUTIN | i3 Pharmaceuticals, LLC | fd6062e2-17c8-48f4-a1fe-69ebe410f583 | 2026-02-20 | Warnings, Adverse reactions | Rifabutin RIFABUTIN |
| Rifabutin | RIFABUTIN | Marlex Pharmaceuticals, Inc. | df7d4103-42e4-4e4f-e053-2a95a90a8ce8 | 2025-11-18 | Warnings, Adverse reactions | Rifabutin RIFABUTIN |
Adverse event summaries are temporarily unavailable. Other product information remains available.